Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics: a new diagnostic frontier.

Glen L Hortin1, Saeed A Jortani, James C Ritchie

  • 1Department of Laboratory Medicine, Intramural research program of the NIH Clinical Center, National Institutes of Health, Bethesda, MD 20892-1508, USA. ghortin@mail.cc.nih.gov

Clinical Chemistry
|May 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Biomarker Panel for the Detection of Pancreatic Cancer.

Cancers·2026
Same author

Laboratory Medicine Approaches for Assessing Delayed Graft Function in Renal Transplant.

The journal of applied laboratory medicine·2026
Same author

A 15-layer multi-omics analysis of gastric cancer ecotypes provides therapeutic insights.

Cell reports. Medicine·2026
Same author

Potassium Reference Intervals: A Need for Separate Reference Intervals for Serum and Plasma.

The journal of applied laboratory medicine·2026
Same author

Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer.

JU open plus·2026
Same author

High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression Analysis.

Analytical chemistry·2026
Same journal

From Pooled Cohorts to PREVENT: A Perspective for Clinical Laboratorians.

Clinical chemistry·2026
Same journal

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

Clinical chemistry·2026
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
See all related articles

Recent advances in proteomics enable the simultaneous analysis of thousands of proteins and protein fragments in plasma. These discoveries hold promise for new clinical diagnostic tests, though challenges remain in their implementation.

Area of Science:

  • Proteomics and clinical chemistry
  • Biomarker discovery

Background:

  • Protein analysis is crucial in clinical chemistry.
  • Genomic advances fuel new protein analysis opportunities for diagnostics.

Framework:

  • Conference summary on proteomics advancements.
  • Focus on high-throughput protein and fragment analysis in biological fluids.

Implementation:

  • Simultaneous analysis of thousands of proteins and protein fragments (peptidome) in plasma.
  • Detection of structural protein variations.
  • Overcoming plasma analytical challenges: complexity, major component predominance, and wide concentration ranges.

Implications:

  • Proteomics offers significant potential for discovering novel clinical laboratory test markers.

Related Experiment Videos

  • Translating proteomic discoveries into validated clinical tests presents considerable challenges.